PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'ICES, Toronto, ON, Canada; Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada.\', \'ICES, Toronto, ON, Canada.\', \'ICES, Toronto, ON, Canada; Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada; Women\'s College Research Institute, Toronto, ON, Canada.\', \'ICES, Toronto, ON, Canada; Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada; Public Health Ontario, ON, Canada.\', \'ICES, Toronto, ON, Canada; Women\'s College Research Institute, Toronto, ON, Canada; Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, ON, Canada.\', \'ICES, Toronto, ON, Canada; Department of Medicine, University of Ottawa and Bruyere and Ottawa Hospital Research Institutes, Ottawa, ON, Canada.\', \'Department of Medicine, University of Ottawa and Bruyere and Ottawa Hospital Research Institutes, Ottawa, ON, Canada.\', \'ICES, Toronto, ON, Canada; Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada; Public Health Ontario, ON, Canada; Department of Family and Community Medicine, University of Toronto, Toronto, ON, Canada; University Health Network, Toronto, ON, Canada. Electronic address: jeff.kwong@utoronto.ca.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0264-410X(21)00951-810.1016/j.vaccine.2021.07.060
?:hasPublicationType
?:journal
  • Vaccine
is ?:pmid of
?:pmid
?:pmid
  • 34373124
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.863
?:rankingScore_hIndex
  • 159
?:title
  • Background rates of all-cause mortality, hospitalizations, and emergency department visits among nursing home residents in Ontario, Canada to inform COVID-19 vaccine safety assessments.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all